FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TAZEMETOSTAT
异名/同义词(1,1'-BIPHENYL)-3-CARBOXAMIDE, N-((1,2-DIHYDRO-4,6-DIMETHYL-2-OXO-3-PYRIDINYL)METHYL)-5-(ETHYL(TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(4-MORPHOLINYLMETHYL)-
E7438
E-7438
EPZ6438
EPZ-6438
N-((4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL(OXAN-4-YL)AMINO)-4-METHYL-4'-((MORPHOLIN-4-YL)METHYL)(1,1'-BIPHENYL)-3-CARBOXAMIDE
TAZEMETOSTAT
TAZEMETOSTAT [INN]
TAZEMETOSTAT [MI]
TAZEMETOSTAT [USAN]
TAZEMETOSTAT [WHO-DD]
CAS登记号1403254-99-8
物质唯一标识(Unique Ingredient Identifier)Q40W93WPE1
分子式9963
国际化合物标识(International Chemical Identifier,InChI)FG-162
SMILESC34H44N4O4
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型NSQSAUGJQHDYNO-UHFFFAOYSA-N / N(C1CCOCC1)(c2cc(-c3ccc(CN4CCOCC4)cc3)cc(C(=O)NCc5c(=O)[nH]c(C)cc5C)c2C)CC
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System